ENTITY
China Regenerative Medicine International

China Regenerative Medicine International (8158 HK)

4
Analysis
Health Care • Hong Kong
China Regenerative Medicine International is a high-end new-technology enterprise focused on the research, development, production, and sales of tissue engineering and regenerative medicine products. Its business encompasses tissue engineering, cosmetics, cell storage and therapy, and hospital administration, with key products including ActivSkin and Acornea. The company was incorporated on April 20, 2001, and is headquartered in Hong Kong.
more
•24 Mar 2017 16:32

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...

Share
•06 Feb 2015 15:02

Can Innovation labs be assessed to pick stocks for your portfolio?

Companies across different industries are building Innovation centers  in Singapore, Hong Kong and other cities across Asia and the rest of the...

Logo
936 Views
Share
•22 Jan 2015 07:01

Hutchison Whampoa Restructuring: Next Move for Watson's?

The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...

Share
•03 Jan 2021 07:09

Last Week in Event SPACE: OFAC's Longer List, Haier, Avex, Beijing Jingneng, Naspers/Tencent

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
716 Views
Share
x